We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BF.B icon
1101
Brown-Forman Class B
BF.B
$13.3B
$1.8M ﹤0.01%
22,671
-2,000
-8% -$154K
RRX icon
1102
Regal Rexnord
RRX
$13.5B
$1.8M ﹤0.01%
14,629
-4,500
-24% -$497K
TPTX
1103
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.79M ﹤0.01%
14,724
+1,572
+12% +$172K
JHG
1104
DELISTED
Janus Henderson
JHG
$1.79M ﹤0.01%
54,940
-4,383
-7% -$125K
IIPR icon
1105
Innovative Industrial Properties
IIPR
$1.76B
$1.78M ﹤0.01%
9,703
+1,980
+26% +$296K
KSS icon
1106
Kohl's
KSS
$2.16B
$1.78M ﹤0.01%
43,652
VIRT icon
1107
Virtu Financial
VIRT
$5.11B
$1.77M ﹤0.01%
70,267
+7,303
+12% +$169K
MTB icon
1108
M&T Bank
MTB
$36.6B
$1.76M ﹤0.01%
13,857
-1,531
-10% -$174K
XRX icon
1109
Xerox
XRX
$360M
$1.74M ﹤0.01%
75,195
+5,277
+8% +$112K
HR
1110
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.74M ﹤0.01%
58,749
-27,714
-32% -$833K
WNC icon
1111
Wabash National
WNC
$541M
$1.74M ﹤0.01%
100,772
-7,989
-7% -$129K
LPL icon
1112
LG Display
LPL
$2.93B
$1.73M ﹤0.01%
204,675
-13,635
-6% -$97K
AAMI
1113
Acadian Asset Management
AAMI
$2.94B
$1.73M ﹤0.01%
89,486
+84,400
+1,659% +$1.42M
EVH icon
1114
Evolent Health
EVH
$421M
$1.72M ﹤0.01%
107,304
-8,431
-7% -$111K
NLY icon
1115
Annaly Capital Management
NLY
$17.4B
$1.71M ﹤0.01%
50,588
-1,275
-2% -$39.5K
FPRX
1116
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.7M ﹤0.01%
100,000
EBIX
1117
DELISTED
Ebix Inc
EBIX
$1.7M ﹤0.01%
44,722
MLKN icon
1118
MillerKnoll
MLKN
$1.61B
$1.7M ﹤0.01%
50,175
FCFS icon
1119
FirstCash
FCFS
$9.06B
$1.68M ﹤0.01%
24,033
-1,759
-7% -$111K
WFC.PRL icon
1120
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
$1.67M ﹤0.01%
1,100
+162
+17% +$230K
GEF icon
1121
Greif
GEF
$4.74B
$1.67M ﹤0.01%
35,530
FCX icon
1122
Freeport-McMoran
FCX
$88.6B
$1.66M ﹤0.01%
63,829
-43,000
-40% -$894K
SNDR icon
1123
Schneider National
SNDR
$6.34B
$1.66M ﹤0.01%
80,034
-6,190
-7% -$138K
HBAN icon
1124
Huntington Bancshares
HBAN
$35B
$1.65M ﹤0.01%
131,006
+53,580
+69% +$609K
MTG icon
1125
MGIC Investment
MTG
$6.47B
$1.65M ﹤0.01%
131,266
-417,410
-76% -$4.72M

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.